Article: PP22 Maternal embryonic leucine zipper kinase (MELK) inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease

Your email address will not be published. Required fields are marked *

Your review *

Name *

Email *

Save my name, email, and website in this browser for the next time I comment.

By using this form you agree with the storage and handling of your data by this website. *